Biomaterial-driven in situ cardiovascular tissue engineering : a multi-disciplinary perspective
TLDR
The main current challenges for in situ cardiovascular regeneration are pinpointed and further address, namely the achievement of tissue homeostasis, the development of predictive models for long-term performances of the implanted grafts, and the necessity for stratification for successful clinical translation.Abstract:
There is a persistent and growing clinical need for readily-available substitutes for heart valves and small-diameter blood vessels. In situ tissue engineering is emerging as a disruptive new technology, providing ready-to-use biodegradable, cell-free constructs which are designed to induce regeneration upon implantation, directly in the functional site. The induced regenerative process hinges around the host response to the implanted biomaterial and the interplay between immune cells, stem/progenitor cell and tissue cells in the microenvironment provided by the scaffold in the hemodynamic environment. Recapitulating the complex tissue microstructure and function of cardiovascular tissues is a highly challenging target. Therein the scaffold plays an instructive role, providing the microenvironment that attracts and harbors host cells, modulating the inflammatory response, and acting as a temporal roadmap for new tissue to be formed. Moreover, the biomechanical loads imposed by the hemodynamic environment play a pivotal role. Here, we provide a multidisciplinary view on in situ cardiovascular tissue engineering using synthetic scaffolds; starting from the state-of-the art, the principles of the biomaterial-driven host response and wound healing and the cellular players involved, toward the impact of the biomechanical, physical, and biochemical microenvironmental cues that are given by the scaffold design. To conclude, we pinpoint and further address the main current challenges for in situ cardiovascular regeneration, namely the achievement of tissue homeostasis, the development of predictive models for long-term performances of the implanted grafts, and the necessity for stratification for successful clinical translation.read more
Citations
More filters
Posted ContentDOI
Inflammatory and regenerative processes in bioresorbable synthetic pulmonary valves up to 2 years in sheep: Spatiotemporal insights augmented by Raman microspectroscopy
de Yaw Yvonne Kort,Marzi,Brauchle,Lichauco,Bauer,Serrero,Dekker,Cox,Schoen,Schenke-Layland,Bouten,Smits +11 more
TL;DR: In this paper, the authors used a comprehensive sheep-specific antibody panel, with Raman microspectroscopy for the spatiotemporal analysis of in situ tissue-engineered pulmonary valves with follow-up to 24 months from a previous preclinical study in sheep.
Journal ArticleDOI
Strategies to counteract adverse remodeling of vascular graft: A 3D view of current graft innovations
TL;DR: In this paper , a comprehensive view of cell and scaffold technological innovations in the translational context may benefit the future advancements in vascular grafts, and recommendations for future design endeavors are provided.
Journal ArticleDOI
The Potential Impact and Timeline of Engineering on Congenital Interventions.
TL;DR: Advances in tissue engineering, bioresorbable technology, and even new nanotechnologies and nitinol fabrication techniques which may have an impact on the field of transcatheter congenital device in the next decade are summarized in this review.
Journal ArticleDOI
Multiscale analysis of human tissue engineered matrices for heart valve tissue engineering applications.
Nikolas A. Poulis,P. Breitenstein,Steven Hofstede,Simon P. Hoerstrup,Maximilian Y. Emmert,Emanuela S. Fioretta +5 more
TL;DR: In this article , a longitudinal analysis of the extracellular matrix (ECM) composition in human tissue-engineered matrices (hTEMs) was performed by using gene set enrichment analysis (GSEA) and uniaxial tensile testing.
References
More filters
Journal ArticleDOI
Isolation of putative progenitor endothelial cells for angiogenesis.
Takayuki Asahara,Toyoaki Murohara,Alison Sullivan,Marcy Silver,Rien van der Zee,Tong Li,Bernhard Witzenbichler,Gina C. Schatteman,Jeffrey M. Isner +8 more
TL;DR: It is suggested that EC progenitors may be useful for augmenting collateral vessel growth to ischemic tissues (therapeutic angiogenesis) and for delivering anti- or pro-angiogenic agents, respectively, to sites of pathologic or utilitarianAngiogenesis.
Journal ArticleDOI
Exploring the full spectrum of macrophage activation.
TL;DR: This Review suggests a new grouping of macrophages based on three different homeostatic activities — host defence, wound healing and immune regulation, and proposes that similarly to primary colours, these three basic macrophage populations can blend into various other 'shades' of activation.
Journal ArticleDOI
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica,Alberto Mantovani +1 more
TL;DR: The identification of mechanisms and molecules associated with macrophage plasticity and polarized activation provides a basis for Macrophage-centered diagnostic and therapeutic strategies.
Journal ArticleDOI
Human mesenchymal stem cells modulate allogeneic immune cell responses
TL;DR: Insight is offered into the interactions between allogeneic MSCs and immune cells and mechanisms likely involved with the in vivo MSC-mediated induction of tolerance that could be therapeutic for reduction of GVHD, rejection, and modulation of inflammation.
Journal ArticleDOI
Foreign body reaction to biomaterials.
TL;DR: A major focus of this review is on factors that modulate the interaction of macrophages and foreign body giant cells on synthetic surfaces where the chemical, physical, and morphological characteristics of the synthetic surface are considered to play a role in modulating cellular events.
Related Papers (5)
In situ heart valve tissue engineering using a bioresorbable elastomeric implant - From material design to 12 months follow-up in sheep.
Jolanda Kluin,Hanna Talacua,Anthal I.P.M. Smits,Maximilian Y. Emmert,Marieke Brugmans,Emanuela S. Fioretta,Petra E. Dijkman,Serge H. M. Söntjens,Renee Duijvelshoff,Sylvia Dekker,Marloes W J T Janssen-van den Broek,Valentina Lintas,Aryan Vink,Simon P. Hoerstrup,Simon P. Hoerstrup,Henk M. Janssen,Patricia Y. W. Dankers,Frank P. T. Baaijens,Carlijn V. C. Bouten +18 more
Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model
Benedikt Weber,Petra E. Dijkman,Jacques Scherman,Bart Sanders,Maximilian Y. Emmert,Jürg Grünenfelder,Renier Verbeek,Mona Bracher,Melanie Black,Thomas Franz,Jeroen Kortsmit,Peter Modregger,Peter Modregger,Silvia Peter,Silvia Peter,Marco Stampanoni,Marco Stampanoni,Jerome Robert,Debora Kehl,Marina van Doeselaar,Martin Schweiger,Chad Brokopp,Thomas Wälchli,Thomas Wälchli,Volkmar Falk,Peter Zilla,Anita Anita Driessen-Mol,Frank P. T. Baaijens,Simon P. Hoerstrup +28 more